These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17913707)

  • 1. Identification of in vivo phosphorylation sites and their functional significance in the sodium iodide symporter.
    Vadysirisack DD; Chen ES; Zhang Z; Tsai MD; Chang GD; Jhiang SM
    J Biol Chem; 2007 Dec; 282(51):36820-8. PubMed ID: 17913707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
    Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
    Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity.
    De la Vieja A; Reed MD; Ginter CS; Carrasco N
    J Biol Chem; 2007 Aug; 282(35):25290-8. PubMed ID: 17606623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity.
    Li CC; Ho TY; Kao CH; Wu SL; Liang JA; Hsiang CY
    J Biomed Sci; 2010 Nov; 17(1):89. PubMed ID: 21092238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
    De La Vieja A; Ginter CS; Carrasco N
    J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
    Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
    J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
    Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
    Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
    Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma.
    Gaertner FC; Rohde F; Mueller J; Blechert B; Janssen KP; Essler M
    Int J Cancer; 2009 Dec; 125(12):2783-91. PubMed ID: 19569179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter.
    Zhang Z; Liu YY; Jhiang SM
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6131-40. PubMed ID: 16105966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.
    Martín M; Modenutti CP; Peyret V; Geysels RC; Darrouzet E; Pourcher T; Masini-Repiso AM; Martí MA; Carrasco N; Nicola JP
    Endocrinology; 2019 Jan; 160(1):156-168. PubMed ID: 30496374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
    Paroder V; Nicola JP; Ginter CS; Carrasco N
    J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Thr-354 in the human sodium/iodide symporter (NIS) by site-directed mutagenesis.
    Tatsumi KI; Fujiwara H; Tanaka S; Amino N
    Endocr J; 2010; 57(11):997-9. PubMed ID: 20834191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.
    Smith VE; Sharma N; Watkins RJ; Read ML; Ryan GA; Kwan PP; Martin A; Watkinson JC; Boelaert K; Franklyn JA; McCabe CJ
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2876-86. PubMed ID: 23678037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter.
    De la Vieja A; Ginter CS; Carrasco N
    Mol Endocrinol; 2005 Nov; 19(11):2847-58. PubMed ID: 15976004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.
    Smith VE; Read ML; Turnell AS; Watkins RJ; Watkinson JC; Lewy GD; Fong JC; James SR; Eggo MC; Boelaert K; Franklyn JA; McCabe CJ
    J Cell Sci; 2009 Sep; 122(Pt 18):3393-402. PubMed ID: 19706688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.